• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素治疗急性脑静脉窦血栓形成患者的预后:脑内出血时间模式的影响

Outcome of heparin-treated patients with acute cerebral venous sinus thrombosis: influence of the temporal pattern of intracerebral haemorrhage.

作者信息

Busch M A, Hoffmann O, Einhäupl K M, Masuhr F

机构信息

Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.

Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Eur J Neurol. 2016 Sep;23(9):1387-92. doi: 10.1111/ene.13064. Epub 2016 Jun 14.

DOI:10.1111/ene.13064
PMID:27297773
Abstract

BACKGROUND AND PURPOSE

The influence of temporal patterns of intracerebral haemorrhage (ICH) on the outcome of heparin-treated patients with cerebral venous sinus thrombosis (CVST) has not been examined systematically.

METHODS

Temporal patterns of ICH and their influence on survival without disability (modified Rankin Scale score ≤1 point) at hospital discharge were examined in 141 consecutive hospital-admitted patients with acute CVST who were treated with intravenous unfractionated heparin.

RESULTS

Of all 141 patients (median age 40 years; 73% women), 59 (42%) had ICH at the time of diagnosis (early ICH). Of these, seven (12%) subsequently had extension of ICH and 13 (22%) had additional ICHs at other locations (delayed ICH). Of 82 patients without early ICH, nine (11%) later had delayed ICH. After a median hospital stay of 26 days, 107 patients (76%) were discharged without disability. Patients with early ICH were less likely to survive without disability until discharge than those without early ICH [63% vs. 85%; risk ratio (RR) 0.73; P = 0.005]. The association was attenuated after adjusting for age, sex and impaired consciousness on admission (RR 0.83; P = 0.03). Taking temporal patterns of ICH into account, early ICH with subsequent complication (extension or delayed ICH) had a larger influence on survival without disability (RR 0.57; 95% confidence interval 0.35-0.95) than early ICH without complications (RR 0.78; 95% confidence interval 0.67-0.91).

CONCLUSIONS

Heparin-treated CVST patients were less likely to survive without disability when ICH was present on admission. This association may largely be driven by subsequent extension of haemorrhage or additionally occurring delayed haemorrhage.

摘要

背景与目的

尚未系统研究脑出血(ICH)的时间模式对接受肝素治疗的脑静脉窦血栓形成(CVST)患者预后的影响。

方法

在141例连续入院并接受静脉普通肝素治疗的急性CVST患者中,研究ICH的时间模式及其对出院时无残疾生存(改良Rankin量表评分≤1分)的影响。

结果

在所有141例患者(中位年龄40岁;73%为女性)中,59例(42%)在诊断时即有ICH(早期ICH)。其中,7例(12%)随后出现ICH扩展,13例(22%)在其他部位出现额外的ICH(延迟ICH)。在82例无早期ICH的患者中,9例(11%)后来出现延迟ICH。中位住院26天后,107例患者(76%)出院时无残疾。有早期ICH的患者出院时无残疾生存的可能性低于无早期ICH的患者[63%对85%;风险比(RR)0.73;P = 0.005]。在调整年龄、性别和入院时意识障碍后,这种关联减弱(RR 0.83;P = 0.03)。考虑到ICH的时间模式,有后续并发症(扩展或延迟ICH)的早期ICH对无残疾生存的影响(RR 0.57;95%置信区间0.35 - 0.95)大于无并发症的早期ICH(RR 0.78;95%置信区间0.67 - 0.91)。

结论

入院时存在ICH的肝素治疗CVST患者无残疾生存的可能性较小。这种关联可能主要由随后的出血扩展或额外发生的延迟出血所驱动。

相似文献

1
Outcome of heparin-treated patients with acute cerebral venous sinus thrombosis: influence of the temporal pattern of intracerebral haemorrhage.肝素治疗急性脑静脉窦血栓形成患者的预后:脑内出血时间模式的影响
Eur J Neurol. 2016 Sep;23(9):1387-92. doi: 10.1111/ene.13064. Epub 2016 Jun 14.
2
Cerebral venous sinus thrombosis associated with cerebral hemorrhage: is anticoagulant treatment safe?伴有脑出血的脑静脉窦血栓形成:抗凝治疗安全吗?
Neurologist. 2011 Jul;17(4):208-10. doi: 10.1097/NRL.0b013e31821a259b.
3
Heparin treatment in cerebral sinus and venous thrombosis: patients at risk of fatal outcome.肝素治疗脑静脉窦血栓形成:有致命结局风险的患者。
Cerebrovasc Dis. 2003;15(1-2):17-21. doi: 10.1159/000067117.
4
Association of admission clinical predictors and functional outcome in patients with Cerebral Venous and Dural Sinus Thrombosis.脑静脉和硬脑膜窦血栓形成患者入院临床预测因子与功能结局的相关性。
Clin Neurol Neurosurg. 2020 Jan;188:105563. doi: 10.1016/j.clineuro.2019.105563. Epub 2019 Nov 9.
5
Cerebral venous congestion as indication for thrombolytic treatment.脑静脉淤血作为溶栓治疗的指征。
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):675-87. doi: 10.1007/s00270-007-9046-1.
6
Heparin treatment in sinus venous thrombosis.静脉窦血栓形成的肝素治疗
Lancet. 1991 Sep 7;338(8767):597-600. doi: 10.1016/0140-6736(91)90607-q.
7
The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis.脑静脉窦血栓形成患者的颅内血肿、出血性梗死、非出血性梗死和非病变性静脉性卒中的临床谱。
Eur J Neurol. 2012 Apr;19(4):537-43. doi: 10.1111/j.1468-1331.2011.03562.x. Epub 2011 Oct 28.
8
EFNS guideline on the treatment of cerebral venous and sinus thrombosis.欧洲神经科学联合会关于脑静脉和静脉窦血栓形成治疗的指南。
Eur J Neurol. 2006 Jun;13(6):553-9. doi: 10.1111/j.1468-1331.2006.01398.x.
9
Neurointensive care of patients with cerebral venous sinus thrombosis and intracerebral haemorrhage.脑静脉窦血栓形成和脑出血患者的神经重症监护
J Clin Neurosci. 2018 Dec;58:83-88. doi: 10.1016/j.jocn.2018.10.003. Epub 2018 Oct 16.
10
Cerebral Venous Sinus Thrombosis with Cerebral Hemorrhage Presenting with Status Epilepticus in Early Pregnancy.妊娠早期出现癫痫持续状态的伴有脑出血的脑静脉窦血栓形成
Clin Lab. 2018 Apr 1;64(4):611-614. doi: 10.7754/Clin.Lab.2017.171110.

引用本文的文献

1
Malignant Isolated Cortical Vein Thrombosis as the Initial Manifestation of Primary Antiphospholipid Syndrome: Lessons on Diagnosis and Management From a Case Report.恶性孤立性大脑皮层静脉血栓形成作为原发性抗磷脂综合征的初始表现:来自一例病例报告的诊断和治疗经验教训。
Front Immunol. 2022 Apr 25;13:882032. doi: 10.3389/fimmu.2022.882032. eCollection 2022.
2
Updates in Cerebral Venous Thrombosis.脑静脉血栓形成的最新进展。
Curr Cardiol Rep. 2022 Jan;24(1):43-50. doi: 10.1007/s11886-021-01622-z. Epub 2022 Jan 13.
3
Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination.
来自 FACME 特设专家工作组关于管理与 COVID-19 疫苗接种相关的脑静脉窦血栓形成的诊断和治疗建议。
Neurologia (Engl Ed). 2021 Jul-Aug;36(6):451-461. doi: 10.1016/j.nrleng.2021.05.001. Epub 2021 May 29.
4
[Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].[FACME新冠疫苗接种相关脑静脉窦血栓形成管理临时专家工作组的诊断和治疗建议]
Neurologia. 2021 Jul-Aug;36(6):451-461. doi: 10.1016/j.nrl.2021.05.001. Epub 2021 May 6.
5
Seizure in cerebral venous and sinus thrombosis.脑静脉和静脉窦血栓形成中的癫痫发作
Epilepsia Open. 2018 Jun 8;3(3):316-322. doi: 10.1002/epi4.12229. eCollection 2018 Sep.